Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
US Department of Justice
Chinese Patent Office
AstraZeneca
Federal Trade Commission
Baxter
UBS
Citi
Covington

Generated: May 26, 2018

DrugPatentWatch Database Preview

PRECEF Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Precef patents expire, and when can generic versions of Precef launch?

Precef is a drug marketed by Apothecon and Bristol and is included in two NDAs.

The generic ingredient in PRECEF is ceforanide. There is one drug master file entry for this compound. Additional details are available on the ceforanide profile page.
Summary for PRECEF
US Patents:0
Applicants:2
NDAs:2
Bulk Api Vendors: 28
Patent Applications: 1,870
DailyMed Link:PRECEF at DailyMed
Drug patent expirations by year for PRECEF
Synonyms for PRECEF
(6R-trans)-7-(((2-(Aminomethyl)phenyl)acetyl)amino)-3-(((1-(carboxymethyl)-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
(6R,7R)-7-({[2-(aminomethyl)phenyl]acetyl}amino)-3-({[1-(carboxymethyl)-1H-tetrazol-5-yl]sulfanyl}methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-({[2-(aminomethyl)phenyl]acetyl}amino)-3-({[1-(carboxymethyl)-1H-tetrazol-5-yl]thio}methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-(2-(alpha-Amino-o-tolyl)acetamido)-3-(((1-(carboxymethyl)-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[2-[2-(aminomethyl)phenyl]acetyl]amino]-3-[[1-(carboxymethyl)tetrazol-5-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{2-[2-(aminomethyl)phenyl]acetamido}-3-({[1-(carboxymethyl)-1H-1,2,3,4-tetrazol-5-yl]sulfanyl}methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-(aminomethyl)phenyl)acetyl)amino)-3-(((1-(carboxymethyl)-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, (6R-trans)-
60925-61-3
7-(o-(Aminomethyl)phenylacetamido)-3-(((1-(carboxymethyl)-1H-tetrazol-5-yl)thio)methyl)-3-cephem-4-carboxylic acid
7-[O-(aminomethyl)phenylacetamido]-3-[[[1-(carboxymethyl)-1H-tetrazol-5-yl]thio]methyl]-3-cephem-4-carboxylic acid
7beta-[2-(aminomethyl)phenyl]acetamido-3-{[1-(carboxymethyl)-1H-tetrazol-5-yl]sulfanyl}methyl-3,4-didehydrocepham-4-carboxylic acid
8M1YF8951V
925C613
AB00513845
AC1L2A0U
AC1Q6LON
AK481329
AKOS027427040
AN-39394
API0009042
AS-15783
bl s786
BL-S 786
BL-S786
BL-S786R
BPBio1_000638
BRD-K37848908-001-03-1
BSPBio_000580
C06884
C20H21N7O6S2
CAS-60925-61-3
CCG-220470
CEFORANIDE
Ceforanide (USP/INN)
Ceforanide [USAN:INN:BAN]
Ceforanide [USAN:USP:INN:BAN]
ceforanide monosodium salt
Ceforanide sodium
Ceforanido
Ceforanido [INN-Spanish]
Ceforanidum
Ceforanidum [INN-Latin]
CHEBI:3495
CHEMBL1201046
D00259
D06OUL
DB00923
DSSTox_CID_2760
DSSTox_GSID_22760
DSSTox_RID_76719
DTXSID1022760
FT-0698679
HE070958
HE360936
HMS1569M22
HMS2096M22
LS-176135
MolPort-006-167-662
NCGC00016897-01
Precef (TN)
Prestwick0_000470
Prestwick1_000470
Prestwick2_000470
Prestwick3_000470
Q766
Radacef
SC-89759
SCHEMBL122072
SPBio_002519
SR-01000872614
SR-01000872614-3
Tox21_110670
UNII-8M1YF8951V
ZINC3830434

US Patents and Regulatory Information for PRECEF

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apothecon PRECEF ceforanide INJECTABLE;INJECTION 062579-002 Nov 26, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol PRECEF ceforanide INJECTABLE;INJECTION 050554-003 May 24, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apothecon PRECEF ceforanide INJECTABLE;INJECTION 062579-005 Nov 26, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol PRECEF ceforanide INJECTABLE;INJECTION 050554-004 May 24, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Accenture
Chinese Patent Office
QuintilesIMS
McKesson
Daiichi Sankyo
US Department of Justice
Federal Trade Commission
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.